ストックスクリーナーアプリを入手
17.86
1.72%
0.34
前日終値:
$17.52
開ける：
$17.19
24時間の取引高:
325.04K
Relative Volume:
0.38
時価総額：
$1.90B
収益：
$577.74M
当期純損益:
$-149.78M
株価収益率:
-12.76
EPS:
-1.4
ネットキャッシュフロー:
$-78.21M
1週間 パフォーマンス:
-3.36%
1か月 パフォーマンス:
-6.55%
6か月 パフォーマンス:
+14.97%
1年 パフォーマンス:
+23.84%
1日の値動き範囲:
$17.18
$17.88
1週間の範囲:
$17.18
$19.06
52週間の値動き範囲:
$11.70
$34.13
Novocure Ltd Stock (NVCR) Company Profile
NVCR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NVCR
Novocure Ltd
|
17.84 | 1.90B | 577.74M | -149.78M | -78.21M | -1.40 |
|
ABT
Abbott Laboratories
|
131.78 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.37 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.31 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.74 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.91 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Novocure Ltd Stock (NVCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2024-10-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-11-20 | 再開されました | JP Morgan | Neutral |
| 2023-08-28 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-08-08 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | 開始されました | SVB Securities | Outperform |
| 2023-07-31 | アップグレード | Evercore ISI | Underperform → In-line |
| 2023-06-07 | アップグレード | Wedbush | Underperform → Neutral |
| 2023-05-16 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-17 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-01-06 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-01-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2022-11-29 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-10-24 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-07-05 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2022-05-16 | 開始されました | H.C. Wainwright | Buy |
| 2022-02-08 | 開始されました | Loop Capital | Buy |
| 2022-02-02 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-01-20 | アップグレード | Truist | Hold → Buy |
| 2022-01-03 | アップグレード | Evercore ISI | Underperform → In-line |
| 2021-07-01 | ダウングレード | Mizuho | Buy → Neutral |
| 2021-04-14 | ダウングレード | Wedbush | Neutral → Underperform |
| 2021-01-25 | 繰り返されました | Piper Sandler | Overweight |
| 2020-09-23 | 開始されました | Northland Capital | Outperform |
| 2020-09-18 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-09-17 | ダウングレード | Truist | Buy → Hold |
| 2020-06-01 | 再開されました | Oppenheimer | Perform |
| 2020-05-01 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-04-09 | ダウングレード | Evercore ISI | In-line → Underperform |
| 2020-03-05 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-07-29 | アップグレード | SunTrust | Hold → Buy |
| 2019-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-07-26 | ダウングレード | Wedbush | Outperform → Neutral |
| 2019-03-20 | 開始されました | SunTrust | Hold |
| 2018-11-02 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2018-07-16 | 開始されました | Evercore ISI | Outperform |
| 2018-04-18 | 繰り返されました | Mizuho | Buy |
| 2018-02-23 | 繰り返されました | Mizuho | Buy |
| 2017-05-24 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2016-07-29 | 繰り返されました | Wedbush | Outperform |
| 2016-01-19 | 開始されました | Barclays | Underweight |
| 2015-12-02 | 開始されました | Deutsche Bank | Hold |
すべてを表示
Novocure Ltd (NVCR) 最新ニュース
Novocure to Report First Quarter 2025 Financial Results - Yahoo Finance
Emerald Advisers LLC Takes Position in NovoCure Limited (NASDAQ:NVCR) - MarketBeat
Proficio Capital Partners LLC Acquires Shares of 30,158 NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure Limited (NASDAQ:NVCR) Receives Consensus Rating of “Moderate Buy” from Analysts - The AM Reporter
NovoCure Beats Investor Lawsuit Over Cancer Trial Data Results - Bloomberg Law News
Charles Schwab Investment Management Inc. Has $24.92 Million Stake in NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure Beats Investor Suit Over Cancer Therapy Trial Data (1) - Bloomberg Law News
NovoCure (NASDAQ:NVCR) Rating Increased to Hold at StockNews.com - Defense World
Bank of New York Mellon Corp Increases Stock Holdings in NovoCure Limited (NASDAQ:NVCR) - Defense World
An Analysis of NovoCure Ltd (NVCR)’s Potential Price Growth - Knox Daily
Novocure at Leerink’s Global Healthcare Conference: Expanding TTFields - Investing.com India
Novocure at Leerink’s Global Healthcare Conference: Expanding TTFields By Investing.com - Investing.com UK
Principal Financial Group Inc. Invests $272,000 in NovoCure Limited (NASDAQ:NVCR) - Defense World
Novocure Ltd. to Host Earnings Call - ACCESS Newswire
Truist Financial Corp Invests $340,000 in NovoCure Limited (NASDAQ:NVCR) - Defense World
Don't Ignore The Insider Selling In NovoCure - Simply Wall St
Novocure’s EVP sells shares worth $46,841 By Investing.com - Investing.com Australia
Insider Sell Alert: Frank Leonard Sells 15,036 Shares of NovoCure Ltd (NVCR) - GuruFocus.com
Prediction: Novocure (NVCR) Will Beat the Market. Here's Why - MSN
Novocure’s chief innovation officer sells shares worth $5,071 - Investing.com India
Novocure’s EVP sells shares worth $46,841 - Investing.com India
Novocure CEO Ashley Cordova sells shares valued at $38,055 By Investing.com - Investing.com South Africa
Novocure CEO Ashley Cordova sells shares valued at $38,055 - Investing.com
Novocure COO sells shares worth $4,634 By Investing.com - Investing.com Australia
Novocure COO sells shares worth $4,634 - Investing.com
Novocure’s COO Paravasthu Mukund sells shares worth $39,687 By Investing.com - Investing.com Australia
Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference - Yahoo Finance
NovoCure (NASDAQ:NVCR) Lowered to “Sell” Rating by StockNews.com - Defense World
NovoCure Executives Cash In: Major Stock Sales Unveiled! - TipRanks
Insider Sell: Uri Weinberg Sells Shares of NovoCure Ltd (NVCR) - GuruFocus.com
NovoCure’s Earnings Call: Growth Amid Challenges - MSN
Novocure executive sells shares for $296,256 By Investing.com - Investing.com South Africa
Novocure’s COO Paravasthu Mukund sells shares worth $39,687 - Investing.com India
Novocure CEO Ashley Cordova disposes shares worth $266,126 - Investing.com India
Novocure CEO Ashley Cordova disposes shares worth $266,126 By Investing.com - Investing.com Canada
Q1 Earnings Estimate for NovoCure Issued By Leerink Partnrs - Defense World
New York State Common Retirement Fund Increases Holdings in NovoCure Limited (NASDAQ:NVCR) - Defense World
New York State Common Retirement Fund Grows Stake in NovoCure Limited (NASDAQ:NVCR) - Armenian Reporter
Some Confidence Is Lacking In NovoCure Limited (NASDAQ:NVCR) As Shares Slide 25% - Simply Wall St
Los Angeles Capital Management LLC Acquires 55,334 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat
Rhumbline Advisers Buys 3,115 Shares of NovoCure Limited (NASDAQ:NVCR) - Defense World
NovoCure (NASDAQ:NVCR) Posts Earnings Results, Misses Expectations By $0.27 EPS - MarketBeat
Decoding NovoCure Ltd (NVCR): A Strategic SWOT Insight - GuruFocus.com
Commit To Buy NovoCure At $13, Earn 22.3% Using Options - Nasdaq
NovoCure (NASDAQ:NVCR) Shares Gap Down After Earnings Miss - MarketBeat
NovoCure Full Year 2024 Earnings: EPS Misses Expectations - Simply Wall St
NovoCure Ltd (NVCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ... - Yahoo Finance
Novocure Reports Strong 2024 Revenue Growth - TipRanks
NovoCure Reports Wider Than Expected Q4 Loss Despite 21% Jump In Sales, Expects Product Enhancements To Hit Gross Margin In 2025 - Benzinga
Novocure reports Q4 EPS (61c), consensus (34c) - TipRanks
Novocure shares fall as Q4 earnings miss overshadows revenue beat By Investing.com - Investing.com South Africa
Novocure Ltd (NVCR) 財務データ
収益
当期純利益
現金流量
EPS
Novocure Ltd (NVCR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Leonard Frank X | EVP, Pres., Novocure Oncology |
Mar 03 '25 |
Sale |
18.54 |
2,527 |
46,841 |
143,673 |
| Cordova Ashley | Chief Executive Officer |
Mar 03 '25 |
Sale |
18.54 |
2,053 |
38,055 |
204,005 |
| Paravasthu Mukund | Chief Operating Officer |
Mar 03 '25 |
Sale |
18.54 |
250 |
4,634 |
29,173 |
0.44%
0.15%
大文字化:
|
ボリューム (24 時間):